Lupin to market Forest's AeroChamber Plus in the US
This article was originally published in Scrip
Lupinhas signed a multi-year agreement with Forest Laboratoriesto promote and market Forest's AeroChamber Plus line of products in the US. AeroChamber Plus is a valved holding chamber (VHC) device that is used with metered dose inhalers to improve the delivery of medication to the lungs in the treatment of asthma and chronic obstructive pulmonary disease. Lupin's US subsidiary will use its 50-person sales force to promote the product to paediatricians. The company also expects the alliance to help extend its presence in the respiratory segment and strengthen its franchise with paediatricians. AeroChamber Plus is the most widely prescribed holding chamber in the US and about two thirds of AeroChamber Plus VHC prescriptions (IMS 2007) are written by paediatricians.